Trial · NCT01259297
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Composite Cardiovascular Endpoints in Aliskiren Based Regimen Versus Non-Aliskiren Based Regimen | Aliskiren Based Regimen | 11 | participants | ||
| Number of Participants With Composite Cardiovascular Endpoints in Aliskiren Based Regimen Versus Non-Aliskiren Based Regimen | Non-Aliskiren Based Regimen | 14 | participants | ||
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Aliskiren Based Regimen | Community Cognition | -0.04 | Standard Deviation 0.768 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Non-Aliskiren Based Regimen | Community Cognition | -0.05 | Standard Deviation 0.741 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Aliskiren Based Regimen | Instrumental Activities of daily Living (IADL) | -0.06 | Standard Deviation 0.562 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Non-Aliskiren Based Regimen | Instrumental Activities of daily Living (IADL) | -0.04 | Standard Deviation 0.505 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Aliskiren Based Regimen | Mobility | 0.01 | Standard Deviation 0.791 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Non-Aliskiren Based Regimen | Mobility | 0.00 | Standard Deviation 0.779 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Aliskiren Based Regimen | ADL | -0.09 | Standard Deviation 0.525 | units on a scale |
| Change From Baseline to End of Study in Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part I) | Non-Aliskiren Based Regimen | ADL | -0.08 | Standard Deviation 0.520 | units on a scale |
| Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) | Aliskiren Based Regimen | change from Baseline to 6 week (n=821,867) | -11.9 | Standard Error 0.50 | mmHg |
| Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) | Non-Aliskiren Based Regimen | change from Baseline to 6 week (n=821,867) | -8.02 | Standard Error 0.48 | mmHg |
| Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) | Aliskiren Based Regimen | change from baseline to 6 month (n=730,775) | -10.1 | Standard Error 0.52 | mmHg |
| Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) | Non-Aliskiren Based Regimen | change from baseline to 6 month (n=730,775) | -6.8 | Standard Error 0.50 | mmHg |
| Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) | Aliskiren Based Regimen | change from baseline to 12 month (n=397,399) | -7.7 | Standard Error 0.68 | mmHg |
| Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) | Non-Aliskiren Based Regimen | change from baseline to 12 month (n=397,399) | -5.8 | Standard Error 0.68 | mmHg |
| Number of Participants With Composite Cardiovascular Endpoints in Aliskiren+Amlodipine/HCTZ Group Versus All Placebo Group | Aliskiren+Amlodipine/HCTZ Group | 2 | participants | ||
| Number of Participants With Composite Cardiovascular Endpoints in Aliskiren+Amlodipine/HCTZ Group Versus All Placebo Group | Placebo | 8 | participants | ||
| Percentage of Participants With Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part II) | Aliskiren Based Regimen | Normal | 44.2 | percentage of participants | |
| Percentage of Participants With Standard Assessment of Global Activities in the Elderly (SAGE) Dimensions (Part II) | Non-Aliskiren Based Regimen | Normal | 46.5 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01259297/results